Table 2.
Intraindividual comparison of lesion uptake FDG vs. Pentixafor
| Patient no. | Localization of the lesion | Quantitative analyses | Visual analyses | Adeno/SCC | CXCR4 expressionb | ||
|---|---|---|---|---|---|---|---|
| FDG SUVmax | Pentixafor SUVmax | FDGa | Pentixafora | ||||
| #1 | paratracheal left | 2.2 | 5.2 | 0 | 2 | SCC | 1 |
| #2 | mediastinal | 10.1 | 3.2 | 2 | 0 | SCC | 4 |
| infraclavicular | 3.4 | 4.5 | 2 | 1 | |||
| #3 | hip | 7.1 | 2.7 | 2 | 2 | Adeno | 1 |
| thigh | 10.5 | 3.9 | 2 | 2 | |||
| adrenal gland left | 3.3 | 2.9 | 2 | 2 | |||
| left paraaortal lymph node | 3.3 | 1.3 | 1 | 0 | |||
| #4 | esophagus | 7.3 | 5.9 | 2 | 2 | SCC | 3 |
| coeliacal | 9,0 | 5,2 | 2 | 2 | |||
| axillary right | 0,85 | 1,73 | 0 | 2 | |||
| hilary right | 2,0 | 3,5 | 0 | 2 | |||
| gastric curvature | 5,6 | 4,1 | 2 | 2 | |||
| #5 | esophagus | 6.6 | 6.5 | 2 | 2 | Adeno | 0 |
| #6 | mediastinal | 14.4 | 4.2 | 2 | 0 | Adeno | 2 |
| #7 | mediastinal | 15.8 | 4.8 | 2 | 2 | SCC | 3 |
| #8 | adrenal gland left | 2.5 | 5.0 | 2 | 1 | SCC | 4 |
| esophagus | 3.3 | 3.9 | 1 | 0 | |||
| lung upper lobe | 4.9 | 1.5 | 2 | 0 | |||
| #9 | adrenal gland left | 2.7 | 12.0 | 0 | 2 | SCC | 2 |
| #10 | infracarinal | 2.7 | 9.1 | 0 | 2 | SCC | 4 |
| mediastinal | 4.1 | 9.8 | 1 | 2 | |||
| supra right | 2.2 | 5.4 | 0 | 2 | |||
| supra left | 2.8 | 6.6 | 0 | 2 | |||
| esophagus | 14.4 | 3.7 | 2 | 1 | |||
| rib left | 9.2 | 3.8 | 2 | 1 | |||
| cervical left | 13.7 | 4.1 | 2 | 1 | |||
| SUM | 26 | ||||||
Adeno Adenocarcinoma, MPB Mediastinal blood pool, SCC Squamous cell cancer
a 0= < MBP, 1 ≥ MBP, 2 ≤ Liver
b 0 = no CXCR4; 1 = low CXCR4; 2 = intermediate; 3 = strong; 4 = not available